2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow TNX-102 SL: new trials by email Literature Review of TNX-102 SL trials Research Report on TNX-102 SL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese Subjects TNX-102 SL - Healthy Subjects (HS) | Phase 1 | Completed | Tonix Pharmaceuticals, Inc. | 20 | 2022-03-18 | 2026-03-11 |
| Dose-Proportionality and Food Effect Study of TNX-102 SL TNX-102 SL - Healthy Subjects | Phase 1 | Completed | Tonix Pharmaceuticals, Inc. | 16 | 2019-10-14 | 2020-01-06 |
Tonix Pharmaceuticals, Inc. (2)
Canada (1) · United States (1)
Denis Audet, MD (1)